Equities

Braster SA

BRA:WSE

Braster SA

Actions
Health CareHealth Care Providers
  • Price (PLN)0.58
  • Today's Change0.00 / 0.00%
  • Shares traded15.26k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 04 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in PLNIncome statement in PLNView more

Year on year Braster SA had revenues fall -88.96% from 2.89m to 319.00k, though the company grew net income from a loss of 6.66m to a smaller loss of 4.75m.
Gross margin93.66%
Net profit margin-1,513.38%
Operating margin-1,108.80%
Return on assets-20.43%
Return on equity--
Return on investment-147.09%
More ▼

Cash flow in PLNView more

In 2023, cash reserves at Braster SA fell by 91.00k. Cash Flow from Financing totalled 1.81m or 568.34% of revenues. In addition the company used 1.91m for operations while cash from investing was breakeven.
Cash flow per share-0.0527
Price/Cash flow per share--
Book value per share-0.1717
Tangible book value per share-0.1899
More ▼

Balance sheet in PLNView more

Braster SA has a Debt to Total Capital ratio of 177.33%.
Current ratio0.5246
Quick ratio0.2905
Total debt/total equity--
Total debt/total capital1.77
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.